Xconomy National

Archives

by in
Entry Author Date Location
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move Luke Timmerman 11/08/10 Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline Luke Timmerman 09/29/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back Stewart Lyman 06/11/10 Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News Luke Timmerman 01/14/10 Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News Luke Timmerman 01/07/10 Seattle
ZymoGenetics On the Prowl to Raise $85M in Stock Deal Luke Timmerman 01/06/10 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News Luke Timmerman 12/24/09 Seattle
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away Luke Timmerman 12/21/09 Seattle
Zymo Application Yanked in EU Luke Timmerman 12/14/09 Seattle
ZymoGenetics Axes 52 Jobs, Quits Discovery of Immunology Drugs, to Conserve Cash Luke Timmerman 12/03/09 Seattle
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding Luke Timmerman 11/09/09 Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding Luke Timmerman 10/26/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News Luke Timmerman 08/27/09 Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival Luke Timmerman 08/20/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety Luke Timmerman 08/20/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News Luke Timmerman 08/06/09 Seattle
Zymo Gets $6M in Q2 Recothrom Sales Luke Timmerman 08/03/09 Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market Luke Timmerman 05/05/09 Seattle
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash Luke Timmerman 04/29/09 Seattle
ZymoGenetics Sales Chief Exits Luke Timmerman 02/04/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex Luke Timmerman 01/05/09 Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology Luke Timmerman 12/09/08 National
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial Luke Timmerman 12/08/08 Seattle
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow Luke Timmerman 11/04/08 Seattle
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients Luke Timmerman 10/22/08 Seattle
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug Luke Timmerman 09/08/08 Seattle
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval Luke Timmerman 09/02/08 Seattle
ZymoGenetics Sells Land for $11.5 Million Luke Timmerman 08/29/08 Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace Luke Timmerman 08/06/08 Seattle
ZymoGenetics Receives $100 Million Commitment From Deerfield Luke Timmerman 06/30/08 Seattle
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.